Some novel phthiocol and menadione thiosemicarbozone derivatives as potential anticancer and antimicrobial agents.
D000818:Animals; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000138:chemical synthesis*; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000627:therapeutic use; D002176:Candida albicans / Q000187:drug effects; D003500:Cyclization; D004926:Escherichia coli / Q000187:drug effects; D007942:Leukemia, Experimental / Q000188:drug therapy; D051379:Mice; D013211:Staphylococcus aureus / Q000187:drug effects; D013882:Thiosemicarbazones / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000970:Antineoplastic Agents; D013882:Thiosemicarbazones